New Hampton, New York. July 25, 2017. Balchem Corporation (NASDAQ: BCPC) today announced that a conference call will be held on Friday, August 4, 2017 at 11:00 AM Eastern Time (ET) to review second quarter 2017 results. Ted Harris, Chairman of the Board, CEO and President, and Bill Backus, Chief Financial Officer, will host the call.
Second quarter results will be published prior to the market opening on Friday, August 4, 2017. The press release, and its accompanying financial exhibits, will also be available on the Company website, www.balchem.com, prior to the conference call.
We invite you to listen to the conference by calling toll-free 1-877-407-8289 (local dial-in 1-201-689-8341), five minutes prior to the scheduled start time of the conference call. The conference call will be available for replay two hours after the conclusion of the call through end of day Friday, August 18, 2017. To access the replay of the conference call, dial 1-877-660-6853 (local dial-in 1-201-612-7415), and use conference ID #13667775.
About Balchem Corporation Balchem Corporation reports four business segments: Human Nutrition & Health; Animal Nutrition & Health; Specialty Products; and Industrial Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market. The Industrial Products segment manufactures and supplies certain derivative products into industrial applications.
Ted Harris, Chairman, President and CEO said, "We delivered solid second quarter financials with record earnings from operations and adjusted EBITDA. I am particularly pleased with the excellent performance in our Human Nutrition and Health and Specialty Products segments, both delivering strong sales and earnings growth."
Join Ted Harris, Chairman of the Board, President, and CEO and Martin Bengtsson, CFO on Friday, October 25, 2024, at 11:00 AM Eastern Time (ET) to review 3rd Quarter 2024 financial results.
×
You are leaving the Balchem Corporation website and linking to a non-affiliated third-party site.
